---
title: "RA Capital Management disposes of Werewolf Therapeutics shares worth $145,069"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290485642.md"
description: "RA Capital Management sold 416,911 shares of Werewolf Therapeutics (HOWL) on June 17, 2026, at a weighted average price of $0.35, totaling approximately $145,069. Following this transaction, RA Capital Healthcare Fund holds 4,268,448 shares, and RA Capital Nexus Fund II holds 303,719 shares."
datetime: "2026-06-22T23:00:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290485642.md)
  - [en](https://longbridge.com/en/news/290485642.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290485642.md)
---

# RA Capital Management disposes of Werewolf Therapeutics shares worth $145,069

-   RA Capital Management, a 10% owner of Werewolf Therapeutics (HOWL), reported selling 416,911 common shares on June 17, 2026. \* Sales were reported at a weighted average price of $0.35. \* Holdings fell to 4,268,448 shares in RA Capital Healthcare Fund, 303,719 shares in RA Capital Nexus Fund II. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Werewolf Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000688), on June 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [HOWL.US](https://longbridge.com/en/quote/HOWL.US.md)

## Related News & Research

- [RA Capital Management reports USD 412,776 Artiva Biotherapeutics common share purchase](https://longbridge.com/en/news/294116655.md)
- [RA Capital Management acquires USD 2.62 million of Artiva Biotherapeutics common shares](https://longbridge.com/en/news/293685424.md)
- [RA Capital Management buys USD 6.84 million of Parabilis Medicines common shares](https://longbridge.com/en/news/293521210.md)
- [Saba Capital Management reports $2.67 million BlackRock ESG Capital Allocation Term Trust common share sale](https://longbridge.com/en/news/293651395.md)
- [RA Capital Management reports $1.43 million purchase of Artiva Biotherapeutics shares](https://longbridge.com/en/news/293258566.md)